Indicator | Number of women and infants receiving PMTCT services (numerator) and percentage, out of those eligible (denominator) in pre-intervention and intervention period | % change in number of women & infants receiving PMTCT services before and during the projecta | Person’s Chi2 test p-value comparing % women & infants receiving PMTCT services before and during the project | |
---|---|---|---|---|
Pre-Intervention Period (2006–2010) | Intervention Period (2011–2015) | |||
Pregnant women booked for ANC | 59% (1,176,003/1,985,076) | 97% (2,048,283/2,105,205) | 74% | < 0.001 |
Pregnant women tested for HIV in ANC | 80% (941,293/1,176,003) | 99% (1,953,814/1,972,936) | 108% | < 0.001 |
HIV-positive pregnant women dispensed ARVS | 24% (34,330/141,064) | 74% (123,547/167,839) | 260% | < 0.001 |
HIV-positive pregnant women CD4 tested | 11% (15,543/141,064) | 62% (123,578/197,788) | 695% | < 0.001 |
HIV-positive pregnant women initiated ART | 2% (3287/141,064) | 42% (83,494/197,788) | 2440% | < 0.001 |
HIV-exposed infants initiated ARV prophylaxis | 70% (98,898/141,064) | 85% (244,814/287,543) | 148% | < 0.001 |
Infants HIV tested using DNA PCR < 2 months | 9% (12,494 /141,064) | 58% (167,291/287,543) | 1239% | < 0.001 |